An observational study in Accident, Traffic, sponsored by University Hospital, Caen. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-22.
Sponsored by University Hospital, Caen · Observational
Drugs responsible for cognitive and psychomotor side effects may lead to impaired driving skills and road traffic accidents. This study investigates reports of road traffic accident for different class of drugs responsible for cognitive and psychomotor sides effects (pyschotropic agents, neurotropic agents, antineoplasic agents) in the World Health Organization's (WHO) global database of individual safety case reports (VigiBase).
Some medications are responsible of a wide range of cognitive and psychomotor side effects that may make it unsafe to drive and lead to risks of road accidents .The investigators use VigiBase, the World Health Organization (WHO) database of individual safety case reports, to identify cases of road traffic accidents following treatment with different class of drugs responsible for pyschomotor sides effects.
University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients treated With Drugs Responsible for Cognitive and Psychomotor Side Effects
Exclusion Criteria:
Road traffic accidents cases reported in the World Health Organization (WHO) and the French pharmacovigilance database of patients treated by Drugs Responsible for Cognitive and Psychomotor Side Effects
Drug: Drugs Responsible for Cognitive Side Effects
identification of road traffic accidents associated with drugs responsible for psychomotor side effects
Also known as: Drugs Responsible for Pyschomotor Side Effects
Association between drugs responsible for cognitive and psychomotor side effects and road traffic accidents cases
Identification of cases with association between each individual of different class of drugs responsible for cognitive ans psychomotor side effects and road traffic accidents cases
Time frame: Case reported in the World Health Organization (WHO) of individual safety case reports to March 2020
Association between two drugs of the same class, leading to an over-reporting of road traffic accidents
Association between two drugs in the different class studied and road traffic accidents cases to search for a potential interaction between two drugs of the same class, leading to an over-reporting of road traffic accidents
Time frame: Case reported in the World Health Organization (WHO) of individual safety case reports to March 2020
Description of the population of patients having a road traffic accident related to taking medication
Identification of the population criteria (age, sex ...) having road accidents related to certain classes of drugs
Time frame: Case reported in the World Health Organization (WHO) of individual safety case reports to March 2020
This study is status unknown, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Caen